<?xml version="1.0"?>
<Articles JournalTitle="Frontiers in Biomedical Technologies">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Frontiers in Biomedical Technologies</JournalTitle>
      <Issn>2345-5837</Issn>
      <Volume>8</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>06</Month>
        <Day>30</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Accurate Quantification of Choline-to-Creatine Ratio as a Biomarker to Distinguish Osteosarcoma Patients from Normal Subjects Employing Proton Magnetic Resonance Spectroscopy Imaging at 3 Tesla</title>
    <FirstPage>94</FirstPage>
    <LastPage>101</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Shaghayegh</FirstName>
        <LastName>Karimi Alavijeh</LastName>
        <affiliation locale="en_US">Department of Medical Physics and Biomedical Engineering, School of Medicine,Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fakhereh</FirstName>
        <LastName>Pashaei</LastName>
        <affiliation locale="en_US">Radiation Sciences Research Center, Aja University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mahrooz</FirstName>
        <LastName>Malek</LastName>
        <affiliation locale="en_US">Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hamidreza</FirstName>
        <LastName>Saligheh Rad</LastName>
        <affiliation locale="en_US">Medical Physics and Biomedical Engineering Department, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>01</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>02</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Purpose: This study focused on accurate quantification of a maximum of Choline-to-Creatine ratio (Max (Cho/Cr)) in 10 Osteosarcoma patients, in comparison with 5 healthy volunteers as our control group using proton Magnetic Resonance Spectroscopy Imaging (1H-MRSI).
&#xD;

Materials and Methods: Max (Cho/Cr) were obtained in 10 patients with Osteosarcoma over their corresponding ratio maps containing diseased tissue, to be compared with Cho/Cr in 5 healthy volunteers at 3T, employing MRSI (Performed Employing Pointed-resolved Spectroscopy (PRESS), TR/TE: 2500s /135 ms) with water-suppression. An extra unsuppressed water Single-Voxel Spectroscopy (SVS) was acquired to provide phase information for further Eddy Current Correction (ECC). Multi-stage preprocessing was applied. Subtract QUEST MRSI as a time-domain technique was employed to accurately quantify the metabolites&#x2019; ratios and to estimate the baseline.
&#xD;

Results: An optimal database for Subtract QUEST was achieved based on multiple trials evaluated by acceptable peak-fitting and Cramer-Rao-Bound (CRB). Lipids at frequencies of 0.94 and 1.33ppm were combined to increase the accuracy of the Lipid estimation.
&#xD;

Conclusion: Estimation of Max (Cho/Cr) evaluated over Cho/Cr spatial maps to distinguish Osteosarcoma patients from normal subjects suggested that the proposed quantification method leads to high power and linear classifier with a high degree of reproducibility, considering 1H-MRSI at 3T machine as a high efficacy diagnostic tool for musculoskeletal radiology.</abstract>
    <web_url>https://fbt.tums.ac.ir/index.php/fbt/article/view/307</web_url>
  </Article>
</Articles>
